AKT1 and central nervous system cancer: However, our findings demonstrate that niclosamide is able to inhibit PI3K/AKT and MAPK/ERK signaling in human glioma U-87 MG cells, which, to the best of our knowledge, has not been reported in any previous cancer studies.